Introduction to Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop
If you are looking for information about Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop, you have come to the right place. Jochem Gokemeijer, PhD. - Pre-clinical
Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop Comprehensive Overview
Peter Marks, MD. PhD. – Welcome Remarks. Lora Hamuro, PhD. - Quantitative Morten Nielsen, PhD. - The use of HLA class II antigen presentation prediction in the context of
Nirjal Bhattarai, PhD. - mmunogenicity of Chimeric Antigen Receptor T Cells.
Summary & Highlights for Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop
- Richard White, PhD. and Sophie Rhodes, Ph.D - Using Epidemiological and Immunostimulation/Immunodynamic
- Malachi Griffith, PhD. - Bioinformatics and immunogenomics
- Guangping Gao, PhD. - Vector-related
- Andrzej Kierzek, PhD. - Quantitative Systems Pharmacology to predicting and managing impact of
- Peter Gilbert, PhD. - Learning Immune Correlates of Protection from Vaccine Efficacy Trials.
We hope this detailed breakdown of Model Informed Drug Development Approaches For Immunogenicity Assessments Workshop was helpful.